Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.

Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.

Item
http://www.wikidata.org/entity/Q33516524
Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedemaTopical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a reviewProstaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.Ocular pharmacokinetics of 0.45% ketorolac tromethamineNonsteroidal anti-inflammatory drugs for retinal disease.Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgeryTopical nonsteroidal anti-inflammatory drugs for macular edema.Inflammation and macular oedema after pars plana vitrectomy.Efficacy and vitreous levels of topical NSAIDs.Alternative Drug Delivery for Patients Undergoing Cataract Surgery as Demonstrated in a Canine Model.A randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degeneration.The Effect of Perioperative Topical Ketorolac 0.5% on Macular Thickness after Uneventful Phacoemulsification.
P2860

Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.

Item
http://www.wikidata.org/entity/Q33516524
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@ast
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@en
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@nl
type
label
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@ast
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@en
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@nl
prefLabel
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@ast
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@en
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Vitreous nonsteroidal antiinfl ...... nac 0.09%, and nepafenac 0.1%.
@en
P2093
P304
P31
P356
10.1097/IAE.0B013E3181B094E6
P433
P478
P577
P698